Related Experiment Video
Updated: Apr 16, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
New insights on biomarkers in systemic vasculitis
Rodolfo Perez-Alamino1, Hernán Maldonado-Ficco
1Rheumatology Section, Hospital Nicolás Avellaneda, 2000 Catamarca Street, Tucumán, Argentina, ofo_pa@hotmail.com.
Systemic vasculitis, an inflammatory blood vessel disease, has seen improved understanding and therapies. New biomarkers are needed to differentiate active disease from damage or infection and predict treatment outcomes.
Area of Science:
- Immunology
- Rheumatology
- Internal Medicine
Background:
- Systemic vasculitis encompasses diverse diseases marked by blood vessel inflammation.
- Advances in diagnostics and genetics have enhanced understanding of vasculitis pathogenesis and treatment development.
Purpose of the Study:
- To address the unmet need in systemic vasculitis management.
- To focus on developing novel biomarkers for disease assessment and prognosis.
Main Methods:
- Review of current diagnostic and genetic studies in vasculitis.
- Analysis of existing therapeutic approaches and their limitations.
Main Results:
- Current understanding of vasculitis pathogenesis has significantly improved.
- Newer therapies have been developed based on enhanced knowledge.
Conclusions:
- Despite progress, a critical need exists for biomarkers in systemic vasculitis.
- Biomarkers are essential for distinguishing active disease from damage/infection and predicting treatment response and prognosis.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Endocarditis II: Clinical Features of Infective Endocarditis
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Inflammatory Response I: Vascular and Cellular

